FDA names renowned oncologist Dr. Pazdur to lead drug evaluation center
The US Food and Drug Administration (FDA) has appointed Dr. Richard Pazdur as the new head of its Center for Drug Evaluation and Research (CDER). The move comes after the previous director, Dr. George Tidmarsh, resigned following an investigation and a lawsuit.
Dr. Pazdur brings a wealth of experience to the role. He is an oncologist and expert in cancer management, having previously served as a professor at the University of Texas M.D. Anderson Cancer Center in Houston. Before joining the FDA, he led the Oncology Drug Products division and founded the Oncology Center of Excellence. Dr. Pazdur has authored over 800 articles and two medical oncology textbooks, demonstrating his deep understanding of the field.
Dr. Pazdur's leadership abilities have been recognised by many, including FDA Commissioner Dr. Marty Makary. He was also named one of the 50 World's Greatest Leaders by Fortune magazine in 2015. In his new role, Dr. Pazdur will oversee the safety and regulation of most prescription drugs, over-the-counter medicines, and other products like antiperspirants, sunscreens, and fluoride toothpaste.
Dr. Pazdur expressed his honor in leading the CDER at a time of regulatory reforms. He will continue to lead the Oncology Center of Excellence until a successor is chosen, ensuring a smooth transition. The FDA's appointment of Dr. Pazdur is expected to bring valuable expertise and leadership to the CDER.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Over 1.7M in Baden-Württemberg at Poverty Risk, Emmendingen's Housing Crisis Urgent
- Life Expectancy Soars, But Youth Suicide and Substance Abuse Pose Concern
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
